Our lab has an open position for a postdoctoral researcher interested in translational drug delivery and nanomedicine! RT appreciated! 🧪🧫🥼
https://t.co/4meXmCuble
“It appears that the Pfizer vaccine boosted antibody responses remarkably in one-dose AstraZeneca vaccinees. This is all around wonderful news.” https://t.co/QjMr82q13P
We are looking for new members, PhDs & postdoc @CNRS_Paris@Sorbonne_Univ_ in Paris, @Nano_lcmcp to work in nanomaterials science. RT appreciated 🙏 Details & formal applications there: https://t.co/OwtKkzPp1c https://t.co/YTCAl2z5Rf https://t.co/NTxgPEOKq7
I have created Bioicons - a library of 1632+ free, high quality science illustrations in vector format easily searchable and filterable specifically for the life science community. All icons are under permissive CC0 or CC BY license. ➡️ https://t.co/H7CawgOOiJ
Pfizer unveils the first orally administered inhibitor of the SARS-CoV-2 main protease to enter clinical trials. Inhibiting this protease will prevent the virus from cleaving parts it needs to reproduce itself. Our reporter, @beth_halford, has more at https://t.co/hlluZCHYKi
We are changing the way of using CE-LIF with our 'magic' buffers.
A second application for magnetic nanoparticles, after the first one on exosomes
https://t.co/hms6t2EqsR
More will come soon :) @ClaireSmadja @MyriamTaverna@marco_morani@TLienardMayor#teamPNAS